Sanofi (EPA:SAN)
88.20
-3.77 (-4.10%)
May 30, 2025, 3:20 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
€544,970
Profits / Employee
€76,003
Market Cap
112.04B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Clariane SE | 61,798 |
Sanofi News
- 1 hour ago - Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data - Benzinga
- 2 hours ago - Sanofi, Regeneron fall after late-stage data for COPD therapy - Seeking Alpha
- 6 hours ago - Sanofi, Regeneron's Itepekimab Delivers Mixed Results in Late-Stage Trials - WSJ
- 1 day ago - Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs - GlobeNewsWire
- 1 day ago - Sanofi granted FDA label expansion for MenQuadfi meningococcal shot for infants - Seeking Alpha
- 3 days ago - US FDA approves use of Sanofi's meningococcal vaccine in infants - Reuters
- 3 days ago - C4X Discovery receives latest milestone payment from Sanofi - GlobeNewsWire
- 3 days ago - Sanofi, VNVC launch vaccine factory in Vietnam - Reuters